Annual Report — [x] Reg. S-K Item 405 — Form 10-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K405 Form 10-K405 for 12-31-2001 39 208K
2: EX-2.1 Agreement & Plan of Merger 54 231K
3: EX-4.2 Amend No.1 to Shareholder Rights Agreement 3 16K
6: EX-10.12 Amend 1 to Long Term Incentive Plan 1 6K
7: EX-10.13 Amend 2 to Long Term Incentive Plan 2 10K
4: EX-10.4 Amend 1 to Employment Agreement 2 13K
5: EX-10.6 Amend 1 to Change in Control Agreement 3 15K
8: EX-21.1 Subsidiaries 1 4K
9: EX-23.1 Consent of Ernst & Young LLP 1 7K
EX-4.2 — Amend No.1 to Shareholder Rights Agreement
| EX-4.2 | 1st Page of 3 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
|---|
Exhibit 4.2
CYTRX CORPORATION
154 Technology Parkway
Norcross, Georgia 30092
February 11, 2002
American Stock Transfer & Trust Company
40 Wall Street
New York, New York 10005
Attention: Corporate Trust Department
Re: Amendment No. 1 to Shareholder Protection Rights Agreement dated as of
April 16, 1997 (the "Rights Agreement") between CytRx Corporation
("CytRx") and American Stock Transfer & Trust Company ("AST")
Ladies and Gentlemen:
Pursuant to Section 5.4 of the Rights Agreement, CytRx, by resolution
adopted by its board of directors, hereby amends the Rights Agreement as
follows:
1. The definition of "Acquiring Person" in Section 1.1 of the Rights
Agreement is hereby deleted and replaced in its entirety with the following:
"Acquiring Person" shall mean any Person who is a Beneficial Owner of 15% or
more of the outstanding shares of Common Stock; provided, however, that the
term "Acquiring Person" shall not include any Person (i) who is the Beneficial
Owner of 15% or more of the outstanding shares of Common Stock on the date of
this Agreement or who shall become the Beneficial Owner of 15% or more of the
outstanding shares of Common Stock solely as a result of an acquisition by the
Company of shares of Common Stock, until such time hereafter or thereafter as
any of such Persons shall become the Beneficial Owner (other than by means of
stock dividend or stock split) of any additional shares of Common Stock, (ii)
who, on or after the date of this Agreement, is or shall become the Beneficial
Owner of 15% or more of the outstanding shares of Common Stock (or securities
convertible into, exchangeable into or exercisable for Common Stock) pursuant to
the Agreement and Plan of Merger dated as of February 11, 2002 (the "Merger
Agreement") among the Company, Global Genomics Capital, Inc. and GGC Merger
Corporation or the Merger (as defined in the Merger Agreement or other
transactions contemplated by the Merger Agreement, until such time hereafter or
thereafter as such Person shall become the Beneficial Owner (other than (1) by
means of a stock dividend, stock split or other similar event or (2) pursuant to
the exercise of any stock option granted by the Company's board of directors or
compensation committee on or after the date of this Agreement to such Person in
such Person's capacity as an officer or
director of the Company) of any additional shares of Common Stock, (iii) who
is the Beneficial Owner of 15% or more of the outstanding shares of Common
Stock but who acquired Beneficial Ownership of shares of Common Stock without
any plan or intention to seek or affect control of the Company, if such Person
promptly enters into an irrevocable commitment promptly to divest, and
thereafter promptly divests (without exercising or retaining any power,
including voting power, with respect to such shares), sufficient shares of
Common Stock (or securities convertible into, exchangeable into or exercisable
for Common Stock) so that such Person ceases to be the Beneficial Owner of 15%
or more of the outstanding shares of Common Stock or (iv) who Beneficially Owns
shares of Common Stock consisting solely of one or more of (A) shares of Common
Stock Beneficially Owned pursuant to the grant or exercise of an option granted
to such Person by the Company in connection with an agreement to merge with, or
acquire, the Company entered into prior to a Flip-In Date, (B) shares of Common
Stock (or securities convertible into, exchangeable into or exercisable for
Common Stock) acquired by Affiliates or Associates of such Person after the time
of such grant which, in the aggregate, amount to less than 1% of the outstanding
shares of Common Stock. In addition, the Company, any wholly owned Subsidiary of
the Company and any employee stock ownership or other employee benefit plan of
the Company or a wholly owned Subsidiary of the Company shall not be an
Acquiring Person.
2. The definition of "Stock Acquisition Date" in Section 1.1 of the
Rights Agreement is hereby amended by adding the following sentence to the
end thereof:
"Neither the Merger Agreement nor the Merger or any other transaction
contemplated thereby shall cause a Stock Acquisition Date."
3. The definition of "Separation Time" in Section 1.1 of the Rights
Agreement is hereby amended by adding the following sentence to the end thereof:
"Neither the Merger Agreement nor the Merger or any other transaction
contemplated thereby shall cause a Separation Time."
4. Section 5.4 of the Rights Agreement is hereby amended by adding the
following sentence to the end thereof:
"Notwithstanding the above, from the Effective Time (as defined in the
Merger Agreement) until the second anniversary thereof, no amendment or
supplement may be made to this Agreement, and no such amendment or supplement
shall be effective, without the prior approval of a majority of the
then-disinterested members of the Company's board of directors."
5. Except as expressly amended hereby, the Rights Agreement shall
remain in full force and effect.
6. Capitalized terms used herein and not otherwise defined herein shall have
the meaning ascribed to them in the Rights Agreement.
7. This Amendment No. 1 shall be governed by and construed in accordance with
the laws of the State of Delaware, without regard to the conflicts of
law principles thereof.
8. This Amendment No. 1 may be executed in any number of counterparts and
each of such counterparts shall be deemed to be an original and all of which
together shall be deemed to be one and the same agreement.
9. This Amendment No. 1 to the Rights Agreement shall be effective as of the
date hereof, and all references to the Rights Agreement shall, from and
after such time, be deemed to be references to the Rights Agreement as amended
hereby.
Very truly yours,
CytRx Corporation
By: /s/ Jack J. Luchese
----------------------
Name: Jack J. Luchese
---------------------
Title: President & CEO
--------------------
Accepted and agreed to as of the date first written above:
American Stock Transfer & Trust Company
By: /s/ Herbert J. Lemmer
--------------------------
Name: Herbert J. Lemmer
------------------------
Title: Vice President
-----------------------
Dates Referenced Herein and Documents Incorporated by Reference
↑Top
Filing Submission 0000931763-02-001057 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Mon., Apr. 29, 3:03:01.1am ET 
